Julia Geynisman-Tan, MD
Urogynecology and Reconstructive Pelvic Surgery · Chicago, ILNPI 1831465806
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,695 of the $2,106 with a category attached, or 80.5%. 7 manufacturers reported payments, led by Medtronic at 35.0% of the total. 2025 is the largest year on record at $1,157, 5.6 times the $206 reported in 2019. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in IL, where the typical reported total is $2,778.
Across 31 payments — averaging $67.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$738
- Boston Scientific$549
- Kerecis Limited$467
- Axonics, Inc.$235
- AbbVie$58
- Coloplast$42
- plus $17 from 1 others
Across 6 payments — averaging $16,166 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$97K
What the payments were for
- Travel & lodging$41120%
- Food & beverage$1,69580%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $738 |
| Boston Scientific | 9 | $549 |
| Kerecis Limited | 8 | $467 |
| Axonics, Inc. | 4 | $235 |
| AbbVie(2 entities) | 2 | $58 |
| Coloplast | 1 | $42 |
| Intuitive Surgical | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$1,217
- ALTAVIVA$331
- Kerecis GraftGuide$304
- SOLYX$251
- INTERSTIM$133
- Advantage System$103
- Axonics$102
How this compares
$2,106 in reported general payments places this provider in the 40th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 59 | $49,590 |
| MyrbetriqMirabegron | 95 | $46,432 |
| Estradiol | 107 | $7,073 |
| Trospium Chloride ErTrospium Chloride | 13 | $836 |
| Clobetasol Propionate | 14 | $396 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $292 |
| Solifenacin Succinate | 11 | $282 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Chicago
- Abraham ShashouaChicago$339K
- Akira GillinghamChicago$58K
- Kimberly KentonChicago$43K
- Traci BeckChicago$32K
- Margaret MuellerChicago$26K
- Carol BretschneiderChicago$14K
- Trieu DoChicago$11K
- Sean GeorgeChicago$9K
- Thythy PhamChicago$8K
- Ankita GuptaChicago$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.